Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Kilitch Drugs (India) Ltd
BSE: 524500 | NSE: KILITCH | ISIN: INE729D01010
Market Cap: [Rs.Cr.] 29 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations
Discuss this stock
Key Ratios
Years
Mar-12
Mar-11
Mar-10
Mar-09
Mar-08
Debt-Equity Ratio
0.3
0.6
0.6
0.7
1.0
Long Term Debt-Equity Ratio
0.0
0.1
0.3
0.4
0.6
Current Ratio
0.7
1.2
1.6
1.5
1.0
Fixed Assets
2.3
2.0
2.1
2.0
2.0
Inventory
11.7
10.2
11.1
8.9
10.8
Debtors
4.1
3.4
2.8
2.7
4.7
Interest Cover Ratio
34.6
4.5
3.9
3.5
4.2
PBIDTM (%)
97.6
15.1
16.8
18.6
19.6
PBITM (%)
93.2
11.3
12.5
13.8
14.3
PBDTM (%)
94.9
12.6
13.6
14.6
16.2
CPM (%)
75.7
10.8
11.6
13.4
15.0
APATM (%)
71.3
7.1
7.3
8.6
9.7
ROCE (%)
77.6
13.1
16.4
18.6
26.8
RONW (%)
77.9
13.1
15.0
19.3
34.9
PE
1.1
7.7
13.6
8.3
13.1
EBIDTA
106.8
22.4
23.9
23.9
23.0
DivYield
49.2
1.7
0.9
1.5
1.9
PBV
0.7
0.9
1.9
1.4
2.8
EPS
54.1
7.7
7.8
8.3
8.2
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
13-Feb-13
Kilitch Drugs (India) net profit declines 76.84% in the December 2012 quarter
06-Feb-13
Kilitch Drugs India's chairman passed away
16-Jan-13
Kilitch Drugs India to disinvest its entire stake in Eye Kare Kilitch
12-Jan-13
Kilitch Drugs India to hold board meeting
01-Sep-12
Record date for Kilitch Drugs India special interim dividend fixed
30-Aug-12
Kilitch Drugs India declares special interim dividend
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma
2,220.35
21.96
6.23
5.40
27.3
24.2
0.72
Plethico Pharma.
697.24
60.55
1.27
33.34
-5.5
3.8
1.08
Sharon Bio-Med.
361.89
7.02
1.98
9.58
19.1
14.1
1.85
Bliss GVS Pharma
306.72
5.23
1.46
2.15
28.0
42.7
0.04
Venus Remedies
292.27
5.11
0.75
3.54
17.7
16.9
0.72
Kappac Pharma
271.33
0.00
11.31
0.00
0.0
0.0
0.06
Parenteral Drugs
262.19
0.00
1.04
58.93
-16.1
-0.7
0.86
Ahlcon Parent(I)
247.72
19.24
4.58
22.59
12.6
17.0
0.59
Syncom Formul.
246.86
70.96
2.95
13.86
4.3
6.7
0.09
Amrutanjan Healt
192.14
16.35
1.93
9.89
12.6
16.3
0.23
Arvind Remedies
154.34
3.80
1.14
6.60
15.1
16.1
2.12
Combat Drugs
105.96
0.00
18.32
0.00
0.3
0.3
0.07
Zenotech Lab.
103.29
0.00
2.00
0.00
0.0
0.0
0.08
Hester Bios
94.46
11.62
1.57
4.56
14.4
20.6
0.35
Caplin Point Lab
93.68
6.03
3.09
1.38
29.3
33.1
0.30
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Mukund P Mehta , Managing Director
Paresh P Mehta , Joint Managing Director
Bhavin M Mehta , Director
Mukesh Shah , Director
Company Head Office / Quarters:
C-301/2 MIDC TTC Indl Area,
Pawane Village,
Thane,
Maharashtra-400705
Phone : 91-022-27670322/27680913/65144185
Fax : 91-022-27680912
E-mail :
info@kilitch.com
Web :
http://www.kilitch.in
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
Bharat Forge | Oil India | Container Corpn.
View full month Results calendar